Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2019-07-19 Director's Dealing
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-07-19 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates that the filing announces a press release about clinical study follow-up data, specifically 36 weeks of follow-up data from a Phase IIb study and long-term follow-up data from a Phase I/II study. There are no financial statements or detailed financial data included, only a reference to a press release attached as an exhibit. The document length is 3570 characters, which is relatively short and consistent with an announcement rather than a full report. The content does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a certification or officer attestation. The document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes current reports like Form 8-K announcements.
2019-07-09 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 19, 2019, reporting the submission of matters to a vote of security holders at uniQure's 2019 Annual General Meeting (AGM). It details the voting results on various agenda items such as adoption of annual accounts, discharge of board liability, re-election of a director, authorization of share issuance, appointment of auditor, and advisory votes on executive compensation. The content is focused on the official results of shareholder votes at the AGM, which matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the AGM presentation materials themselves, nor is it an annual report or other financial report. It is also not a proxy statement or a regulatory filing unrelated to voting results. Therefore, the correct classification is DVA with high confidence.
2019-06-24 English
PRIMARY DOCUMENT
Director's Dealing
2019-06-20 English
PRIMARY DOCUMENT
Director's Dealing
2019-06-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 22, 2019. It reports an event under Item 8.01 (Other Events) about a press release announcing the strengthening of the company's intellectual property portfolio. The document is short (3823 characters) and primarily serves as a current report to announce a specific event rather than providing detailed financial data or comprehensive reporting. It includes a press release as an exhibit but does not contain financial statements or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2019-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.